|
Volumn 484, Issue 7393 SUPPL., 2012, Pages
|
Drugs: An injection of hope
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
ALEMTUZUMAB;
CLADRIBINE;
CROTONIC ACID DERIVATIVE;
DRUG DERIVATIVE;
FINGOLIMOD;
FUMARIC ACID DERIVATIVE;
FUMARIC ACID DIMETHYL ESTER;
LAQUINIMOD;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
PROPANEDIOL DERIVATIVE;
QUINOLONE DERIVATIVE;
SPHINGOSINE;
TERIFLUNOMIDE;
TOLUIDINE DERIVATIVE;
NOTE;
PRIORITY JOURNAL;
ANIMAL;
ARTICLE;
DISEASE COURSE;
DRUG TOXICITY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNOLOGY;
INFLAMMATION;
MULTIPLE SCLEROSIS;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
RISK ASSESSMENT;
UNITED STATES;
ANIMALS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CLADRIBINE;
CLINICAL TRIALS, PHASE III AS TOPIC;
CROTONIC ACIDS;
DISEASE PROGRESSION;
DRUG TOXICITY;
FUMARATES;
HUMANS;
INFLAMMATION;
MULTIPLE SCLEROSIS;
PROPYLENE GLYCOLS;
QUINOLONES;
RISK ASSESSMENT;
SPHINGOSINE;
TOLUIDINES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84861941976
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature11109 Document Type: Note |
Times cited : (1)
|
References (0)
|